137 related articles for article (PubMed ID: 12354987)
1. Prostate: high-frequency Doppler US imaging for cancer detection.
Halpern EJ; Frauscher F; Strup SE; Nazarian LN; O'Kane P; Gomella LG
Radiology; 2002 Oct; 225(1):71-7. PubMed ID: 12354987
[TBL] [Abstract][Full Text] [Related]
2. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score.
Nelson ED; Slotoroff CB; Gomella LG; Halpern EJ
Urology; 2007 Dec; 70(6):1136-40. PubMed ID: 18158034
[TBL] [Abstract][Full Text] [Related]
3. Optimal combinations for detection of prostate cancer: systematic sextant and laterally directed biopsies versus systematic sextant and color Doppler-targeted biopsies.
Kravchick S; Cytron S; Peled R; London D; Sibi Y; Ben-Dor D
Urology; 2004 Feb; 63(2):301-5. PubMed ID: 14972476
[TBL] [Abstract][Full Text] [Related]
4. High-frequency Doppler US of the prostate: effect of patient position.
Halpern EJ; Frauscher F; Forsberg F; Strup SE; Nazarian LN; O'Kane P; Gomella LG
Radiology; 2002 Mar; 222(3):634-9. PubMed ID: 11867778
[TBL] [Abstract][Full Text] [Related]
5. Effect of dutasteride therapy on Doppler US evaluation of prostate: preliminary results.
Ives EP; Gomella LG; Halpern EJ
Radiology; 2005 Oct; 237(1):197-201. PubMed ID: 16183933
[TBL] [Abstract][Full Text] [Related]
6. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers.
Kuligowska E; Barish MA; Fenlon HM; Blake M
Radiology; 2001 Sep; 220(3):757-64. PubMed ID: 11526279
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging.
Halpern EJ; Ramey JR; Strup SE; Frauscher F; McCue P; Gomella LG
Cancer; 2005 Dec; 104(11):2373-83. PubMed ID: 16240450
[TBL] [Abstract][Full Text] [Related]
8. Using gray-scale and color and power Doppler sonography to detect prostatic cancer.
Halpern EJ; Strup SE
AJR Am J Roentgenol; 2000 Mar; 174(3):623-7. PubMed ID: 10701599
[TBL] [Abstract][Full Text] [Related]
9. Power doppler ultrasonography guided and random prostate biopsy in prostate cancer diagnosis - a comparative study.
Sohail SK; Sarfraz R; Imran M; Khan NA; Yusuf NW
J Pak Med Assoc; 2015 Jan; 65(1):65-8. PubMed ID: 25831678
[TBL] [Abstract][Full Text] [Related]
10. Prostatic cancer: role of color Doppler imaging in transrectal sonography.
Lavoipierre AM; Snow RM; Frydenberg M; Gunter D; Reisner G; Royce PL; Lavoipierre GJ
AJR Am J Roentgenol; 1998 Jul; 171(1):205-10. PubMed ID: 9648790
[TBL] [Abstract][Full Text] [Related]
11. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer.
Gore JL; Shariat SF; Miles BJ; Kadmon D; Jiang N; Wheeler TM; Slawin KM
J Urol; 2001 May; 165(5):1554-9. PubMed ID: 11342916
[TBL] [Abstract][Full Text] [Related]
12. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection.
Frauscher F; Klauser A; Volgger H; Halpern EJ; Pallwein L; Steiner H; Schuster A; Horninger W; Rogatsch H; Bartsch G
J Urol; 2002 Apr; 167(4):1648-52. PubMed ID: 11912381
[TBL] [Abstract][Full Text] [Related]
13. Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection.
Canto EI; Singh H; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM
J Urol; 2004 Sep; 172(3):900-4. PubMed ID: 15310993
[TBL] [Abstract][Full Text] [Related]
14. Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection.
Gupta I; Freid B; Masarapu V; Machado P; Trabulsi E; Wallace K; Halpern E; Forsberg F
Urology; 2020 Apr; 138():106-112. PubMed ID: 31899231
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: diagnostic performance of real-time shear-wave elastography.
Correas JM; Tissier AM; Khairoune A; Vassiliu V; Méjean A; Hélénon O; Memo R; Barr RG
Radiology; 2015 Apr; 275(1):280-9. PubMed ID: 25599156
[TBL] [Abstract][Full Text] [Related]
16. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
17. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
[TBL] [Abstract][Full Text] [Related]
18. Breast lesions: imaging with contrast-enhanced subharmonic US--initial experience.
Forsberg F; Piccoli CW; Merton DA; Palazzo JJ; Hall AL
Radiology; 2007 Sep; 244(3):718-26. PubMed ID: 17690324
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection.
Mitterberger M; Horninger W; Pelzer A; Strasser H; Bartsch G; Moser P; Halpern EJ; Gradl J; Aigner F; Pallwein L; Frauscher F
Prostate; 2007 Oct; 67(14):1537-42. PubMed ID: 17705242
[TBL] [Abstract][Full Text] [Related]
20. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging.
Beyersdorff D; Taupitz M; Winkelmann B; Fischer T; Lenk S; Loening SA; Hamm B
Radiology; 2002 Sep; 224(3):701-6. PubMed ID: 12202702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
